Therefore, we examined whether the inhibition of MC38 tumor growth in the mice immunized with non-replicable MC38 CRC cells plus 40 μg of rGRA6Nt adjuvant is associated with increased infiltration of CD8+ T cells into the tumors. The gene discussed is CD8A; the disease is neoplasm.